|
⚲
|
| Vivo Capital LLC
✚
|
|
|---|---|
| CRD # | 159868 |
| SEC # | 801-79829 |
| CIK # | 0000167471, 0001674712 |
| AUM | $5.8 BB (2024-03-28) |
| Employees | 72 (60% Investors, 0% Brokers) |
| Phone | 650-688-0818 |
| Address | 192 Lytton Avenue Palo Alto, CA 94301 |
| Source | [IAPD] [EDGAR] [Website] [Twitter] [LinkedIn] [Instagram] |
| Total AUM ($BB) |
|---|
| CIK | Period |
|---|---|
| 0000167471 0001674712 | |
| / | |
| Sector | Form 13F Holdings | Cap ($BB) | Value ($BB) |
|---|---|---|---|
| Capnia Inc | 0.0 | 0.3 | |
| Geron Corp | 0.6 | 0.1 | |
| Harmony Biosciences Holdings Inc | 3.0 | 0.1 | |
| Dyne Therapeutics Inc | 0.3 | 0.1 | |
| Flamel Technologies Sa | 0.1 | 0.1 | |
| Verona Pharma PLC | 0.3 | 0.1 | |
| Terns Pharmaceuticals Inc | 0.1 | 0.0 | |
| ALX Oncology Holdings Inc | 0.3 | 0.0 | |
| Signal Genetics Inc | 0.3 | 0.0 | |
| Catabasis Pharmaceuticals Inc | 0.0 | 0.0 | |
| Silence Therapeutics PLC | 0.3 | 0.0 | |
| Olema Pharmaceuticals Inc | 0.2 | 0.0 | |
| UNUM Therapeutics Inc | 0.6 | 0.0 | |
| Erasca Inc | 0.7 | 0.0 | |
| Tarsus Pharmaceuticals Inc | 0.4 | 0.0 | |
| Delcath Systems Inc | 0.0 | 0.0 | |
| FITS My Style Inc | 0.1 | 0.0 | |
| Celcuity Inc | 0.1 | 0.0 | |
| SERA Prognostics Inc | 0.1 | 0.0 | |
| Compass Pathways PLC | 0.4 | 0.0 | |
| Zai Lab Ltd | 2.6 | 0.0 | |
| Oric Pharmaceuticals Inc | 0.2 | 0.0 | |
| Regulus Therapeutics Inc | 0.0 | 0.0 | |
| Access Pharmaceuticals Inc | 0.0 | 0.0 | |
| Talaris Therapeutics Inc | 0.0 | ||
| Corbus Pharmaceuticals Holdings Inc | 0.0 | 0.0 | |
| IO Biotech Inc | 0.1 | 0.0 | |
| Instil Bio Inc | 0.6 | 0.0 | |
| Engene Holdings Inc | 0.0 | ||
| Verastem Inc | 0.2 | 0.0 | Prev | Page 1 | Next |
| Type | Form D Funds | Date | Sold ($MM) | AUM ($MM) |
|---|---|---|---|---|
| PE | Vivo Capital Fund X LP | [2024-03-28] | 0.0 | 548.0 |
| PE | Vivo Co-Invest C LP | [2024-03-28] | 0.0 | 150.0 |
| Other | Vivo Asia Opportunity Fund Holdings LP | [2023-03-31] | 0.0 | 117.8 |
| VC | Vivo Co-Invest S LP | [2023-03-31] | 0.0 | 50.0 |
| VC | Vivo Innovation Fund II Holdings LP | [2023-03-31] | 180.0 | 339.6 |
| Other | Vivo Opportunity Fund Holdings LP | [2023-03-31] | 634.6 | 1,041.7 |
| PE | Vivo Asia Opportunity Fund LP | [2022-03-31] | 148.5 | 105.4 |
| VC | Vivo Innovation Fund II LP | [2021-03-31] | 180.0 | 209.0 |
| Other | Vivo Opportunity Co-Invest LP | [2020-03-27] | 80.0 | 81.5 |
| PE | Vivo Opportunity Co-Invest W LP | [2020-03-27] | 20.0 | 23.7 |
| View All | ||||
| AUM Breakdown | Accounts | AUM ($BB) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 15 | 5.8 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 15 | 5.8 |
| By Discretionary | ||
| Discretionary | 15 | 5.8 |
| Non-Discretionary | 0 | 0.0 |
| Total | 15 | 5.8 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.4 | |
| United States Persons | 5.4 | |
| Total | 15 | 5.8 |
| Limited Partners | 2011 - 2024 |
|---|---|
| California State Teachers' Retirement System |
| Form D Directors | # Filings | # Firms | 2011 - 2024 | |
|---|---|---|---|---|
| Chen Yu | 23 | |||
| Gaurav Aggarwal | 16 | |||
| Albert Cha | 45 | |||
| Jack Nielsen | 44 | |||
| Frank Kung | 44 | |||
| Michael Chang | 34 | |||
| Edgar Engleman | 29 | |||
| Mahendra Shah | 26 | |||
| Hongbo Lu | 17 | |||
| David Liu | 14 | |||
| View All | ||||
| EDGAR Form | CIK | 2011 - 2024 |
|---|---|---|
| 13F-HR | [0001674712] | |
| 3 | [0001674712] | |
| 4 | [0001674712] | |
| SC 13D | [0001674712] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Vivo Capital LLC | Sinovac Biotech Ltd | [2018-07-11] |
| Comparable Firms | State | AUM ($BB) |
|---|---|---|
|
One Madison Group LLC
✚
|
NY | 6.1 |
|
Riverwood Capital Management LP
✚
|
CA | 6.0 |
|
Cornell Capital LLC
✚
|
NY | 6.0 |
|
The Sterling Group LP
✚
|
TX | 5.9 |
|
Freeman Spogli Management Co LP
✚
|
CA | 5.9 |
|
LLR Management HoldCo LP
✚
|
PA | 5.9 |
|
BV Investment Partners LP
✚
|
MA | 5.7 |
|
Trivest Investment Advisors LLC
✚
|
FL | 5.6 |
|
MGG Investment Group LP
✚
|
NY | 5.6 |
|
PPC Investment Partners LP
✚
|
IL | 5.6 |